212 related articles for article (PubMed ID: 18765127)
21. The resolution of detrusor over activity after medical and surgical treatment in patients with bladder outlet obstruction.
Sriplakich S; Promwatcharanon K
J Med Assoc Thai; 2007 Nov; 90(11):2326-31. PubMed ID: 18181315
[TBL] [Abstract][Full Text] [Related]
22. Detrusor instability with equivocal obstruction: A predictor of unfavorable symptomatic outcomes after transurethral prostatectomy.
Machino R; Kakizaki H; Ameda K; Shibata T; Tanaka H; Matsuura S; Koyanagi T
Neurourol Urodyn; 2002; 21(5):444-9. PubMed ID: 12232878
[TBL] [Abstract][Full Text] [Related]
23. A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams).
Tan AH; Gilling PJ; Kennett KM; Frampton C; Westenberg AM; Fraundorfer MR
J Urol; 2003 Oct; 170(4 Pt 1):1270-4. PubMed ID: 14501739
[TBL] [Abstract][Full Text] [Related]
24. Useful parameters to predict the presence of detrusor overactivity in male patients with lower urinary tract symptoms.
Matsukawa Y; Majima T; Ishida S; Funahashi Y; Kato M; Gotoh M
Neurourol Urodyn; 2020 Jun; 39(5):1394-1400. PubMed ID: 32259358
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of holmium laser enucleation of the prostate (HoLEP) in men with bladder outlet obstruction (BOO) and non-neurogenic bladder dysfunction.
Pyun JH; Kang SG; Kang SH; Cheon J; Kim JJ; Lee JG
Kaohsiung J Med Sci; 2017 Sep; 33(9):458-463. PubMed ID: 28865604
[TBL] [Abstract][Full Text] [Related]
26. Is the short-term outcome of transurethral resection of the prostate affected by preoperative degree of bladder outlet obstruction, status of detrusor contractility or detrusor overactivity?
Tanaka Y; Masumori N; Itoh N; Furuya S; Ogura H; Tsukamoto T
Int J Urol; 2006 Nov; 13(11):1398-404. PubMed ID: 17083391
[TBL] [Abstract][Full Text] [Related]
27. [Male non-neurogenic overactive bladder].
Phé V; Gamé X
Prog Urol; 2020 Nov; 30(14):880-886. PubMed ID: 33220816
[TBL] [Abstract][Full Text] [Related]
28. A randomized controlled trial evaluating low-intensity shockwave therapy for treatment of persistent storage symptoms following transurethral surgery for benign prostatic obstruction.
Hegazy M; Sheir KZ; Gaballah MA; Elshal AM
Prostate Cancer Prostatic Dis; 2024 Jun; 27(2):305-311. PubMed ID: 38553627
[TBL] [Abstract][Full Text] [Related]
29. The 12-year symptomatic outcome of transurethral resection of the prostate for patients with lower urinary tract symptoms suggestive of benign prostatic obstruction compared to the urodynamic findings before surgery.
Masumori N; Furuya R; Tanaka Y; Furuya S; Ogura H; Tsukamoto T
BJU Int; 2010 May; 105(10):1429-33. PubMed ID: 19863522
[TBL] [Abstract][Full Text] [Related]
30. Multiple factors related to detrusor overactivity in Chinese patients with benign prostate hyperplasia.
Liu N; Man LB; He F; Huang GL; Wang H; Li GZ; Wang JW; Lü YW
Chin Med J (Engl); 2012 Nov; 125(21):3778-81. PubMed ID: 23106872
[TBL] [Abstract][Full Text] [Related]
31. A Systematic Review and Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Obstruction: An Update.
Cornu JN; Ahyai S; Bachmann A; de la Rosette J; Gilling P; Gratzke C; McVary K; Novara G; Woo H; Madersbacher S
Eur Urol; 2015 Jun; 67(6):1066-1096. PubMed ID: 24972732
[TBL] [Abstract][Full Text] [Related]
32. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
Elshal AM; Elmansy HM; Elhilali MM
BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908
[TBL] [Abstract][Full Text] [Related]
33. Detrusor underactivity influences the efficacy of TURP in patients with BPO.
Zhu Y; Zhao YR; Zhong P; Qiao BM; Yang ZQ; Niu YJ
Int Urol Nephrol; 2021 May; 53(5):835-841. PubMed ID: 33386583
[TBL] [Abstract][Full Text] [Related]
34. The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic followup of transurethral resection of prostate for bladder outlet obstruction.
Thomas AW; Cannon A; Bartlett E; Ellis-Jones J; Abrams P
J Urol; 2005 Nov; 174(5):1887-91. PubMed ID: 16217330
[TBL] [Abstract][Full Text] [Related]
35. Do Urodynamic Findings Other Than Outlet Obstruction Influence the Decision to Perform a Transurethral Resection of Prostate?
Welk B; McGarry P; Baverstock R; Carlson K; Hickling D
Urology; 2018 Jul; 117():120-125. PubMed ID: 29704587
[TBL] [Abstract][Full Text] [Related]
36. Transurethral needle ablation of the prostate: a urodynamic based study with 2-year followup.
Steele GS; Sleep DJ
J Urol; 1997 Nov; 158(5):1834-8. PubMed ID: 9334612
[TBL] [Abstract][Full Text] [Related]
37. [Overactive bladder after transurethral resection of prostate treated with electroacupuncture therapy and tolterodine].
Shen YZ; Lin X; Lin Q
Zhongguo Zhen Jiu; 2012 May; 32(5):404-8. PubMed ID: 22650123
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for urethral stricture and/or bladder neck contracture after monopolar transurethral resection of the prostate for benign prostatic hyperplasia.
Grechenkov A; Sukhanov R; Bezrukov E; Butnaru D; Barbagli G; Vasyutin I; Tivtikyan A; Rapoport L; Alyaev Y; Glybochko P
Urologia; 2018 Nov; 85(4):150-157. PubMed ID: 30426880
[TBL] [Abstract][Full Text] [Related]
39. [Consequences of prostatic obstruction on bladder function, impact of removal, and management of recurrence after surgery].
de la Taille A; Robert G; Descazeaud A
Prog Urol; 2018 Nov; 28(15):813-820. PubMed ID: 30262261
[TBL] [Abstract][Full Text] [Related]
40. Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents.
Kuo HC
Urology; 2004 May; 63(5):868-72. PubMed ID: 15134967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
